Who is sponsoring NCT04037813?

NCT04037813 is sponsored by Cairo University.

What drugs are being tested in NCT04037813?

Interventions in NCT04037813: Laparoscopic and hysteroscopic tubal occlusion for hydrosalpinx.

What condition does NCT04037813 study?

NCT04037813 studies Tubal Obstruction.

Is NCT04037813 still recruiting?

NCT04037813 is currently completed. Last updated 25 February 2022.

Last reviewed 2022-02-25 · How we verify

NCT04037813

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hysteroscopic Versus Laparoscopic Tubal Occlusion in Cases of Hydrosalpinx and Planning for IVF

Completed NA Last updated 25 February 2022

What this trial tests

NA trial testing Laparoscopic and hysteroscopic tubal occlusion for hydrosalpinx in Tubal Obstruction in 108 participants. Completed in 15 September 2020.

Timeline

15 August 2019

Primary endpoint
15 August 2020

15 September 2020

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	108
Start date	15 August 2019
Primary completion	15 August 2020
Estimated completion	15 September 2020
Sites	1 location across Egypt

Drugs / interventions tested

Laparoscopic and hysteroscopic tubal occlusion for hydrosalpinx

Conditions studied

Tubal Obstruction — all drugs for Tubal Obstruction →

Sponsor

Cairo University

Who can join

Adults 20 to 40, female only, with Tubal Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

compare the efficacy of hysteroscopic tubal occlusion versus laparoscopic tubal occlusion for the patients of communicating hydrosalpinx scheduled for IVF. half of the patients will undergo hysteroscopic tubal occlusion while the other half will undergo laparoscopic tubal occlusion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04037813 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 25 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04037813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing